Peter Cummings, MD
Orthopaedic Surgery · Phoenix, AZNPI 1942285978
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (58.0%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 69.9% of it on its own, with 20 other manufacturers making up the rest. Among orthopaedic surgery clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 266 payments — averaging $524.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$98K
- Amgen$40K
- Radius Health, Inc.$356
- Anika Therapeutics, Inc.$171
- Ferring Pharmaceuticals Inc.$153
- Abbott$138
- plus $885 from 15 others
Across 7 payments — averaging $734.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$5K
What the payments were for
- Royalty or licence$81,00258%
- Consulting fees$14,25010%
- Speaking & faculty fees$28,75921%
- Travel & lodging$10,7518%
- Food & beverage$4,8453%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 55 | $97,617 |
| Amgen(2 entities) | 139 | $40,313 |
| Radius Health, Inc. | 31 | $356 |
| Anika Therapeutics, Inc. | 1 | $171 |
| Ferring Pharmaceuticals Inc. | 9 | $153 |
| Abbott | 1 | $138 |
| Smith+Nephew | 6 | $124 |
| Arthrex | 1 | $121 |
| Arthrosurface Incorporated | 1 | $108 |
| UCB, Inc. | 2 | $99 |
| Johnson & Johnson(2 entities) | 3 | $88 |
| Bioventus LLC | 2 | $66 |
| Stryker | 1 | $50 |
| Pacira Therapeutics, Inc. | 2 | $47 |
| Fidia Pharma USA Inc. | 3 | $42 |
| Impactortho, Inc. | 2 | $39 |
| Dynasplint Systems Inc. | 1 | $22 |
| Orthogenrx Inc. | 1 | $21 |
| Electronic Waveform Lab, Inc. | 2 | $21 |
| Orthofix Medical, Inc. | 2 | $18 |
| Vericel Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Biowick$57,760
- BioWick X$35,165
- EVENITY$31,403
- AperFix II Tibial Fixation$10,625
- AperFix Femoral Fixation$10,625
- Juggerknot$392
- Parcus Suture Anchors$171
- PROCLAIM$138
- BIOLOGICS CONSUMABLES AUTOLOGOUS BLOOD PRODUCTS ANGEL PRP$121
- GlenoJet$108
How this compares
$139,632 in reported general payments places this provider in the 90th percentile of 377 orthopaedic surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Phoenix
- Evan LedermanPhoenix$12M
- James ChowPhoenix$6.1M
- Michael McKeePhoenix$3.4M
- Henry ClarkePhoenix$1.9M
- Samuel HarmsenPhoenix$735K
- Anthony HedleyPhoenix$415K
- Matthew SeidelPhoenix$397K
- David OttPhoenix$380K
- Michael WilminkPhoenix$347K
- Judd CummingsPhoenix$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.